The present application pertains to embodiments of steerable endovascular delivery devices.
Endovascular delivery devices are used in various procedures to deliver prosthetic medical devices or instruments to locations inside the body that are not readily accessible by surgery or where access without surgery is desirable. Access to a target location inside the body can be achieved by inserting and guiding the delivery device through a pathway or lumen in the body, including, but not limited to, a blood vessel, an esophagus, a trachea, any portion of the gastrointestinal tract, a lymphatic vessel, to name a few. In one specific example, a prosthetic heart valve can be mounted in a crimped state on the distal end of a delivery device and advanced through the patient's vasculature (e.g., through a femoral artery) until the prosthetic valve reaches the implantation site in the heart. The prosthetic valve is then expanded to its functional size such as by inflating a balloon on which the prosthetic valve is mounted, or by deploying the prosthetic valve from a sheath of the delivery device so that the prosthetic valve can self-expand to its functional size.
The usefulness of delivery devices is largely limited by the ability of the device to successfully navigate through small vessels and around tight bends in the vasculature, such as through the inferior vena cava or around the aortic arch. Various techniques have been employed to adjust the curvature of a section of a delivery device to help “steer” the valve through bends in the vasculature. Typically, a delivery device employs a pull wire having a distal end fixedly secured to the steerable section and a proximal end operatively connected to an adjustment knob located on a handle of the delivery device outside the body. The pull wire is typically disposed in a pull-wire lumen that extends longitudinally in or adjacent to a wall of the delivery device, for example, a sheath or catheter. Adjusting the adjustment knob, for example, rotating the knob, applies a pulling force on the pull wire, which in turn causes the steerable section to bend.
A drawback of many guide sheaths is that they are prone to undesirable deformation when deflected or flexed. For example, a guide sheath subject to significant curvature, such as when accessing the mitral valve in a transseptal approach, may kink at one or more locations along the radius of curvature, dramatically reducing the inner diameter of the guide sheath and resulting in unpredictable movement of the distal end of the guide sheath. A flexed guide sheath may also “pancake,” in which the cross-section of the catheter is ovalized due to a lack of adherence between the materials of adjacent layers of the sheath. Additionally, a flexed guide sheath may be reduced in length, or foreshortened, due to axial compression of the shaft as it is flexed. Such deformation of the guide sheath, especially at the distal end, can interfere with the precise positioning of an implant at the treatment site. Thus, a need exists for improved steerable shaft devices.
Certain embodiments of the disclosure concern delivery apparatuses with steerable shafts. In a representative embodiment, a delivery apparatus comprises a steerable shaft having a proximal portion, a distal portion, and a pull-wire conduit that extends at least partially through the proximal and distal portions of the shaft. The delivery apparatus further includes a pull wire extending through the pull-wire conduit and having a proximal end portion and a distal end portion. The distal end portion of the pull wire is fixed to the distal portion of the shaft. The delivery apparatus further comprises an adjustment mechanism operatively connected to the proximal end portion of the pull wire and configured to increase and decrease tension in the pull wire to adjust the curvature of the distal portion of the shaft. The distal portion of the shaft comprises a steerable portion having one or more layers. The steerable portion includes a compression-resistance portion incorporated into a respective layer of the steerable portion, and extending angularly along a portion of a cross-section of the layer. The layer of the steerable portion into which the compression-resistance portion is incorporated has a first hardness, and the compression-resistance portion has a second hardness that is greater than the first hardness.
In another representative embodiment, a method comprises inserting a shaft of a delivery apparatus into the body of a patient, the shaft having a proximal portion, a distal portion, and a pull-wire conduit that extends at least partially through the proximal and distal portions. A pull wire extends through the pull-wire conduit, and the distal portion of the shaft comprises a steerable portion having one or more layers. The steerable portion includes a compression-resistance portion incorporated into a respective layer of the steerable portion and extending angularly along a portion of a cross-section of the layer. The layer of the steerable portion into which the compression-resistance portion is incorporated has a first hardness, and the compression-resistance portion has a second hardness that is greater than the first hardness. The method further comprises applying tension to the pull wire to adjust the curvature of the distal portion of the shaft.
In another representative embodiment, a delivery apparatus comprises a steerable shaft having a proximal portion, a distal portion, and a pull-wire conduit that extends at least partially through the proximal and distal portions of the shaft. The delivery apparatus further includes a pull wire extending through the pull-wire conduit and having a proximal end portion and a distal end portion. The distal end portion of the pull wire is fixed to the distal portion of the shaft. The delivery apparatus further comprises an adjustment mechanism operatively connected to the proximal end portion of the pull wire and configured to increase and decrease tension in the pull wire to adjust the curvature of the distal portion of the shaft. The distal portion of the shaft comprises one or more layers and a compression-resistance portion incorporated into a respective layer of the distal portion. The compression-resistance portion extends angularly along a portion of a cross-section of the layer and has a hardness that is greater than a hardness of the layer into which the compression-resistance portion is incorporated. The compression-resistance portion is angularly offset from the pull-wire conduit along the cross-section of the layer.
The foregoing and other objects, features, and advantages of the disclosed technology will become more apparent from the following detailed description, which proceeds with reference to the accompanying figures.
In particular embodiments, a delivery apparatus that can be used to deliver a medical device, tools, agents, or other therapy to a location within the body of a subject can include one or more steerable catheters or sheaths. Examples of procedures in which steerable catheters and sheaths are useful include neurological, urological, gynecological, fertility (e.g., in vitro fertilization, artificial insemination), laparoscopic, arthroscopic, transesophageal, transvaginal, transvesical, transrectal, and procedures including access in any body duct or cavity. Particular examples include placing implants, including stents, grafts, embolic coils, and the like; positioning imaging devices or components thereof, including ultrasound transducers; and positioning energy sources, for example, for performing lithotripsy, RF sources, ultrasound emitters, electromagnetic sources, laser sources, thermal sources, and the like.
In some embodiments, the delivery apparatus includes a steerable shaft such as a guide sheath having one or more delivery catheters coaxially disposed within the guide sheath. In certain configurations, the delivery catheters can comprise one or more balloons at or near a distal end portion of the catheter. In some implementations, the delivery apparatus can be used to deliver a medical device through the vasculature, such as to a heart of the subject. These devices may comprise one or more eccentrically positioned pull wires configured to cause the steerable shaft to curve in a given direction, or to straighten. The steerable shaft can further comprise a steerable portion located near the distal end of the shaft including a compression-resistance portion that reduces foreshortening of the shaft and increases the degree of curvature attainable for a given pulling force applied to the shaft by the pull wires, thereby enhancing the steerability of the delivery apparatus.
In certain embodiments, the delivery apparatus can include one or more catheters coaxially disposed within and movable relative to the guide sheath 104. For example, in the illustrated configuration, the delivery apparatus includes an intermediate catheter configured as a steerable catheter 106 disposed within the guide sheath 104, and an inner catheter configured as a delivery or implant catheter 108 coaxially disposed within the steerable catheter 106. The implant catheter 108 can have a prosthetic device 110 mounted on a distal end of the implant catheter in a radially compressed state. In the illustrated configuration, the prosthetic device 110 is a prosthetic heart valve mounted on an inflatable balloon 112 at the distal end of the implant catheter, and the delivery apparatus can be configured to deliver the prosthetic heart valve 110 to one of the native valves of the heart (the aortic, mitral, pulmonary, or tricuspid valves).
In one specific example, the prosthetic heart valve 110 can be a plastically-expandable prosthetic heart valve, and the inflatable balloon 112 can be configured to expand and deploy the valve 110 at a treatment site. Exemplary configurations of the balloon 112 and implant catheter 108 are further disclosed in U.S. Patent Application Publication Nos. 2013/0030519, 2009/0281619, 2008/0065011, and 2007/0005131, the disclosures of which are incorporated herein by reference in their entireties. Exemplary plastically-expandable prosthetic heart valves are disclosed in U.S. Patent Application Publication Nos. 2010/0036484 and 2012/0123529, which are incorporated herein by reference.
In another example, the delivery apparatus 100 can be used to deliver and deploy a self-expandable prosthetic heart valve (e.g., a prosthetic valve having a frame formed from a shape-memory material, such as nitinol). To deliver a self-expandable prosthetic valve, the prosthetic valve can be loaded into a delivery sheath or sleeve in a radially compressed state and advanced from the distal open end of the sheath at the target location to allow the prosthetic valve to expand to its functional size. The delivery sheath can be the distal end portion of the implant catheter 108, or the distal end portion of another shaft that extends through the guide sheath 104. Further details regarding a self-expandable prosthetic valve and delivery devices for a self-expandable prosthetic valve are disclosed in U.S. Patent Application Publication Nos. 2010/0049313 and 2012/0239142, which are incorporated herein by reference. Additionally, it should be understood that the delivery apparatus 100 can be used to deliver any of various other implantable devices, such as docking devices, leaflet clips, etc.
Referring to
The pull wires 124, 126 can be coupled at one end to a pull ring 144 embedded in the coupling portion 120, and coupled at the opposite end to a control mechanism configured as a rotatable knob 132 of the handle 102 (see
The pull ring 144 and the distal portions of the pull wires 124, 126 are shown in isolation in
Referring to
The first layer 134 extends along the full length of the guide sheath 104, and can be made from (or coated with) a lubricious material (e.g., PTFE) to allow the steerable intermediate catheter 106 to slide relative to the guide sheath 104 within the guide sheath's lumen. As stated above, the first layer 134 can also define the recess 142 of the pull-wire conduit portion 154 in which the pull wires 124, 126 and conduits 128, 130 are received.
The pull-wire conduit encapsulating layer 135 can be disposed between the first inner layer 134 and the helically coiled layer 136, and can have a thickness that varies angularly around the circumference of the guide sheath. For example, with reference to
The helically coiled layer 136 can be formed from, for example, a wire helically wrapped or wound about the pull-wire conduit encapsulating layer 135 or the first layer 134. In the illustrated embodiment, the helically coiled layer 136 can extend from adjacent the pull ring 144 proximally through the coupling portion 120 and the steerable portion 122 to a transition region 146 (
The braided layer 138 can extend over the helically coiled layer 136. In the illustrated configuration, the braided layer 138 can extend from the coupling portion 120 proximate the pull ring 144 proximally to, for example, the pull wire exit 148. The braided layer 138 can be, for example, metal wires braided together in a pattern to form a tubular layer over the helically coiled layer 136. For example, in the illustrated embodiment the braided layer 138 is made from stainless steel or titanium flat wires braided in an over 1 under 1 pattern, although any suitable braid pattern can be used. For example, in another representative embodiment, the wires of the braided layer 138 can be braided in a 1 over 2, under 2 pattern with a pick count of 60 picks per inch (PPI). The braided layer 138 can be configured to, for example, resist undesirable torsional deformation of the guide sheath 104 to allow the guide sheath to transmit torque, which can aid in positioning the implant at the treatment site. The braided layer 138 can also provide crush or kink-resistance properties to the guide sheath 104. In the illustrated configuration, the coupling portion 120 can also include a braided layer 158 disposed beneath the pull ring 144, as shown in
The outer layer 140 can comprise, for example, any of a variety of polymeric materials such as polyamides (e.g., VESTAMID®), polyether block amides (e.g., Pebax®), nylon, or any other suitable biocompatible polymer or combinations thereof along its length. In the illustrated configuration, the pull-wire conduit encapsulating layer 135, the helically coiled layer 136, and the braided layer 138 can terminate distally of the proximal end of the guide sheath 104. For example, in some configurations these layers can terminate at the pull wire exit 148. Proximally of the pull wire exit 148, the outer layer 140 can increase in thickness to maintain a substantially uniform outer diameter along the length of the guide sheath, as illustrated in
Referring to
In certain configurations, the compression-resistance portion 150 can be disposed opposite the pull wire conduits 128, 130. For example, in the illustrated configuration, the compression-resistance portion 150 is angularly offset from the pull wire conduit portion 154 by 180 degrees such that it is located diametrically opposite the pull wire conduits 128, 130. In this configuration, a plane 152 that bisects the pull wire conduit portion 154 also bisects the compression-resistance portion 150, as shown in
The compression-resistance portion 150 can be made from a material having a relatively higher hardness or durometer than the remainder of the outer layer 140 in the steerable portion 122 in which the compression-resistance portion is incorporated. For example, in certain embodiments the compression-resistance portion 150 can have a durometer that is from 1.5 times to 5 times greater than a durometer of the remainder of the outer layer 140 in the steerable portion 122. In some embodiments, the durometer of the compression-resistance portion 150 can be from 2 times to 3 times greater than the durometer of the remainder of the outer layer 140 in the steerable portion 122. In an exemplary embodiment, the compression-resistance portion 150 can be made from PEBAX® having a durometer of 72D, and the remainder of the outer layer 140 of the steerable portion 122 can be made from PEBAX® having a durometer of 25D, such that a ratio of the durometer of the compression-resistance portion 150 and the durometer of the remainder of the outer layer 140 in the steerable portion 122 is 2.9:1. In some embodiments, the ratio of the durometer of the compression-resistance portion 150 to the durometer of the remainder of the outer layer 140 in the steerable portion 122 can be 3:1.
In other embodiments, the compression-resistance portion 150 can be made of any of various materials exhibiting suitable hardness properties, including metals such as stainless steel, titanium, nickel titanium alloys such as nitinol, cobalt chromium, or other polymers. In addition, in certain configurations, the compression-resistance portion need not have a thickness equal to the overall thickness of the outer layer 140. For example, the compression-resistance portion 150 can have a thickness that is less than the overall thickness of the outer layer, and may be encapsulated within the outer layer, as desired. The durometer of the compression-resistance portion 150 can also vary along its length. For example, the proximal portion of the compression-resistance portion 150 can have a relatively lower durometer than the distal portion, or vice versa.
The compression-resistance portion 150 can provide a variety of advantageous characteristics to the steerable portion 122 of the guide sheath 104. For example, the relatively higher durometer of the compression-resistance portion 150 can provide axial strength to the steerable portion 122. This can significantly reduce or prevent undesirable foreshortening of the guide sheath 104, and particularly of the steerable portion 122, when the guide catheter is flexed. More particularly, the compression-resistance portion 150 can reduce axial compression of the guide sheath and associated wrinkling of the material when the guide sheath is flexed compared to when it is in a non-deflected state. Such axial compression and wrinkling of the material can decrease the length of the guide sheath 104 as the material is deformed, and can damage the guide sheath. By reducing or eliminating foreshortening of the guide sheath 104 when it is flexed, the compression-resistance portion 150 can reduce the need for the operator to longitudinally reposition the delivery apparatus (e.g., by advancing or retracting the delivery apparatus through the patient's vasculature) in order to obtain or regain a desired position of the implant at the treatment site after flexing the guide sheath.
Additionally, the location of the compression-resistance portion 150 angularly offset from the pull wire conduits 128, 130 can aid in initiating deformation of the steerable portion 122 of the guide sheath in a specified direction. For example, when the compression-resistance portion 150 is located opposite the pull wire conduits 128, 130, the axial stiffness of the compression-resistance portion can induce deflection of the steerable portion 122 in a direction away from the compression-resistance portion when the guide sheath is flexed, as illustrated in
The compression-resistance portion 150 can also increase the degree of flexion of the distal portion 116 attainable for a given force applied to the distal portion by the pull wires 124, 126, without damaging the guide sheath. The angle of flexion of the distal portion 116 is denoted α, and is illustrated in
Additionally, the compression-resistance portion 150, together with the helically coiled layer 136, and the braided layer 138 described above, can provide significant synergistic advantages that improve the performance of the guide sheath 104 over known steerable sheaths and catheters. For example, the distal portion of an unloaded guide sheath (e.g., a guide sheath without a delivery catheter or other shaft extending through its lumen) having an inner diameter of 22 Fr and including the compression-resistance portion, helically coiled layer, and braided layer features is capable of flexing nearly 355 degrees without kinking, and without significant foreshortening, under a force of 175 N applied by the pull wires. In this example, 50 mm of pull wire travel were required to apply a force of 175 N to the distal portion of the guide sheath. In contrast, for a typical steerable catheter device without the compression-resistance portion and without a delivery catheter or other sheath extending through its lumen, a force of 175 N produces 270 degrees of flexure and requires 60 mm of pull wire travel, and the guide sheath can be expected to foreshorten by 6 mm to 10 mm.
In another example, the distal portion of a guide sheath having an inner diameter of 22 Fr and including the above compression-resistance portion, helically coiled layer, and braided layer features, and loaded with a delivery catheter and an implant catheter extending coaxially within the lumen of the guide sheath, was capable of flexing 270 degrees without kinking, and without significant foreshortening, under a force of 250 N applied by the pull wires. In this example, 40 mm of pull wire travel were required to apply a force of 250 N to the distal portion of the guide sheath. In contrast, for a steerable catheter device without the compression-resistance portion and loaded with a delivery catheter and an implant catheter, a force of 250 N produces 180 degrees of flexure and requires 70 mm of pull wire travel, and the guide sheath can be expected to foreshorten by 6 mm to 10 mm.
In use, the delivery apparatus 100 can be introduced and advanced through the patient's vasculature using any known delivery technique. In a transfemoral procedure, the delivery apparatus can be inserted through a femoral artery and the aorta to access the heart (typically, but not exclusively used for aortic valve replacement). In a transeptal procedure (typically used for aortic or mitral valve replacement), the delivery device can be advanced to the right atrium, such as via a femoral vein, and through the septum separating the right and left ventricles. The disclosed embodiments can be particularly useful for delivering a prosthetic valve to the native mitral valve, as the torqueability of the guide sheath 104 and the relatively high degree of curvature achievable with the distal portion 116 allows for precise positioning of the prosthetic valve at the target site despite the tortuous pathway the delivery apparatus must follow to access the mitral valve in some approaches. In a transventricular procedure, the delivery apparatus can be inserted through a surgical incision made on the bare spot on the lower anterior ventricle wall (typically, but not exclusively used for aortic or mitral valve replacement). In a transatrial procedure, the delivery apparatus can be inserted through a surgical incision made in the wall of the left or right atrium. In a transaortic procedure, the delivery apparatus can be inserted through a surgical incision made in the ascending aorta and advanced toward the heart (typically, but not exclusively used for aortic valve replacement).
In certain of these procedures, the combination of the compression-resistance portion 150, the helically coiled layer 136, and the braided layer 138 can aid in precisely positioning a prosthetic device, such as the heart valve 110, at a treatment site. For example, in a transseptal procedure to access the mitral valve, after the distal end of the delivery apparatus is advanced to the treatment site, the distal portion 116 of the guide sheath 104 can be flexed to axially align the prosthetic valve 110 with the mitral valve (e.g., 180 degrees or more, in certain examples). While the distal portion 116 is in a flexed state, the guide sheath 104 can also be torqued to radially position the prosthetic valve 110 with respect to the mitral valve. The combination of the compression-resistance portion 150, the helically coiled layer 136, and the braided layer 138 can allow the guide sheath to flex without significant foreshortening or kinking, and to be torqued without undesirable torsional deformation of the shaft or associated unpredictable rotational motion of the guide sheath.
It should be understood that in alternative configurations, the components of the disclosed delivery apparatus embodiments can be rearranged without departing from the spirit of the disclosure. For example, the locations of the helically coiled layer 136 and the braided layer 138 can be reversed such that the helically coiled layer is on top of the braided layer. Alternatively, the helically coiled layer 136 and the braided layer 138 can be separated from one another by one or more intermediate layers. Additionally, the compression-resistance portion 150 need not be a respective portion of the outer layer 140, but can be incorporated into any suitable layer in the guide sheath 104. The compression-resistance portion 150 also need not extend along the entire length of the steerable portion 122, but can extend along any suitable portion of the steerable portion. The disclosed compression-resistance portion, helically coiled layer, and braided layer features described herein can also be applicable to other types of steerable catheter devices, such as delivery catheters.
General Considerations
For purposes of this description, certain aspects, advantages, and novel features of the embodiments of this disclosure are described herein. The disclosed methods, apparatus, and systems should not be construed as being limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed embodiments, alone and in various combinations and sub-combinations with one another. The methods, apparatus, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.
Although the operations of some of the disclosed embodiments are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language set forth below. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods. Additionally, the description sometimes uses terms like “provide” or “achieve” to describe the disclosed methods. These terms are high-level abstractions of the actual operations that are performed. The actual operations that correspond to these terms may vary depending on the particular implementation and are readily discernible by one of ordinary skill in the art.
As used in this application and in the claims, the singular forms “a,” “an,” and “the” include the plural forms unless the context clearly dictates otherwise. Additionally, the term “includes” means “comprises.” Further, the terms “coupled” and “associated” generally mean electrically, electromagnetically, or physically (e.g., mechanically or chemically) coupled or linked and does not exclude the presence of intermediate elements between the coupled or associated items absent specific contrary language.
In the context of the present application, the terms “lower” and “upper” are used interchangeably with the terms “inflow” and “outflow”, respectively. Thus, for example, the lower end of the valve is its inflow end and the upper end of the valve is its outflow end.
As used herein, the term “proximal” refers to a position, direction, or portion of a device that is closer to the user and further away from the implantation site. As used herein, the term “distal” refers to a position, direction, or portion of a device that is further away from the user and closer to the implantation site. Thus, for example, proximal motion of a device is motion of the device toward the user, while distal motion of the device is motion of the device away from the user. The terms “longitudinal” and “axial” refer to an axis extending in the proximal and distal directions, unless otherwise expressly defined.
Unless otherwise indicated, all numbers expressing quantities of components, distances, forces, ratios, angles, percentages, and so forth, as used in the specification or claims are to be understood as being modified by the term “about.” Accordingly, unless otherwise indicated, implicitly or explicitly, the numerical parameters set forth are approximations that can depend on the desired properties sought and/or limits of detection under test conditions/methods familiar to those of ordinary skill in the art. When directly and explicitly distinguishing embodiments from discussed prior art, the embodiment numbers are not approximates unless the word “about” is recited. Furthermore, not all alternatives recited herein are equivalents.
In view of the many possible embodiments to which the principles of the disclosed technology may be applied, it should be recognized that the illustrated embodiments are only preferred examples and should not be taken as limiting the scope of the disclosure. Rather, the scope of the disclosure is at least as broad as the following claims.
This application claims the benefit of U.S. Provisional Patent Application No. 62/418,528, filed Nov. 7, 2016, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3874388 | King et al. | Apr 1975 | A |
4340091 | Skelton et al. | Jul 1982 | A |
4506669 | Blake, III | Mar 1985 | A |
4590937 | Deniega | May 1986 | A |
4693248 | Failla | Sep 1987 | A |
4803983 | Siegel | Feb 1989 | A |
5125895 | Buchbinder et al. | Jun 1992 | A |
5171252 | Friedland | Dec 1992 | A |
5195962 | Martin et al. | Mar 1993 | A |
5292326 | Green et al. | Mar 1994 | A |
5327905 | Avitall | Jul 1994 | A |
5363861 | Edwards et al. | Nov 1994 | A |
5368564 | Savage | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5389077 | Melinyshyn et al. | Feb 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5450860 | O'Connor | Sep 1995 | A |
5456674 | Bos et al. | Oct 1995 | A |
5474057 | Makower et al. | Dec 1995 | A |
5478353 | Yoon | Dec 1995 | A |
5487746 | Yu et al. | Jan 1996 | A |
5507725 | Savage et al. | Apr 1996 | A |
5565004 | Christoudias | Oct 1996 | A |
5607462 | Imran | Mar 1997 | A |
5609598 | Laufer et al. | Mar 1997 | A |
5611794 | Sauer et al. | Mar 1997 | A |
5626607 | Malecki et al. | May 1997 | A |
5695504 | Gifford, III et al. | Dec 1997 | A |
5716417 | Girard et al. | Feb 1998 | A |
5727569 | Benetti et al. | Mar 1998 | A |
5741297 | Simon | Apr 1998 | A |
5782746 | Wright | Jul 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5836311 | Borst et al. | Nov 1998 | A |
5843076 | Webster, Jr. et al. | Dec 1998 | A |
5855590 | Malecki et al. | Jan 1999 | A |
5885271 | Hamilton et al. | Mar 1999 | A |
5888247 | Benetti | Mar 1999 | A |
5891017 | Swindle et al. | Apr 1999 | A |
5891112 | Samson | Apr 1999 | A |
5894843 | Benetti et al. | Apr 1999 | A |
5921979 | Kovac et al. | Jul 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5957835 | Anderson et al. | Sep 1999 | A |
5972020 | Carpentier et al. | Oct 1999 | A |
5980534 | Gimpelson | Nov 1999 | A |
6004329 | Myers et al. | Dec 1999 | A |
6010531 | Donlon et al. | Jan 2000 | A |
6017358 | Yoon et al. | Jan 2000 | A |
6086600 | Kortenbach | Jul 2000 | A |
6120496 | Whayne et al. | Sep 2000 | A |
6132370 | Furnish et al. | Oct 2000 | A |
6162239 | Manhes | Dec 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6171295 | Garabedian | Jan 2001 | B1 |
6182664 | Cosgrove | Feb 2001 | B1 |
6193732 | Frantzen et al. | Feb 2001 | B1 |
6193734 | Bolduc et al. | Feb 2001 | B1 |
6200315 | Gaiser et al. | Mar 2001 | B1 |
6241743 | Levin et al. | Jun 2001 | B1 |
6269829 | Chen et al. | Aug 2001 | B1 |
6312447 | Oz et al. | Aug 2001 | B1 |
6461366 | Seguin | Oct 2002 | B1 |
6468285 | Hsu et al. | Oct 2002 | B1 |
6508805 | Garabedian | Jan 2003 | B1 |
6508806 | Hoste | Jan 2003 | B1 |
6508825 | Selmon et al. | Jan 2003 | B1 |
6530933 | Yeung et al. | Mar 2003 | B1 |
6537290 | Adams et al. | Mar 2003 | B2 |
6544215 | Bencini et al. | Apr 2003 | B1 |
6626930 | Allen et al. | Sep 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6709429 | Schaefer | Mar 2004 | B1 |
6764510 | Kimblad | Apr 2004 | B2 |
6770083 | Seguin | Aug 2004 | B2 |
6837867 | Kortelling | Jan 2005 | B2 |
6855137 | Bon | Feb 2005 | B2 |
6866660 | Garabedian | Mar 2005 | B2 |
6913614 | Marino et al. | Jul 2005 | B2 |
6939337 | Parker et al. | Sep 2005 | B2 |
6942654 | Schaefer | Sep 2005 | B1 |
6945956 | Waldhauser | Sep 2005 | B2 |
7048754 | Martin et al. | May 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7125421 | Tremulis et al. | Oct 2006 | B2 |
7288097 | Seguin | Oct 2007 | B2 |
7371210 | Brock et al. | May 2008 | B2 |
7464712 | Oz et al. | Dec 2008 | B2 |
7509959 | Oz et al. | Mar 2009 | B2 |
7682369 | Seguin | Mar 2010 | B2 |
7731706 | Potter | Jun 2010 | B2 |
7744609 | Allen et al. | Jun 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7753932 | Gingrich et al. | Jul 2010 | B2 |
7758596 | Oz et al. | Jul 2010 | B2 |
7780723 | Taylor | Aug 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7824443 | Salahieh et al. | Nov 2010 | B2 |
7981123 | Seguin | Jul 2011 | B2 |
7985214 | Garabedian | Jul 2011 | B2 |
7988724 | Salahieh et al. | Aug 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8070805 | Vidlund et al. | Dec 2011 | B2 |
8096985 | Legaspi et al. | Jan 2012 | B2 |
8133239 | Oz et al. | Mar 2012 | B2 |
8147542 | Maisano et al. | Apr 2012 | B2 |
8206437 | Bonhoeffer et al. | Jun 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
8313525 | Tuval et al. | Nov 2012 | B2 |
8323241 | Salahieh | Dec 2012 | B2 |
8348995 | Tuval et al. | Jan 2013 | B2 |
8348996 | Tuval et al. | Jan 2013 | B2 |
8414643 | Tuval et al. | Apr 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8449606 | Eliasen et al. | May 2013 | B2 |
8460368 | Taylor et al. | Jun 2013 | B2 |
8470028 | Thornton et al. | Jun 2013 | B2 |
8480730 | Maurer et al. | Jul 2013 | B2 |
8540767 | Zhang | Sep 2013 | B2 |
8568472 | Marchand | Oct 2013 | B2 |
8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
8608736 | Kaufmann | Dec 2013 | B2 |
8652202 | Alon | Feb 2014 | B2 |
8668733 | Haug et al. | Mar 2014 | B2 |
8708953 | Salahieh | Apr 2014 | B2 |
8721665 | Oz et al. | May 2014 | B2 |
8740918 | Seguin | Jun 2014 | B2 |
8771347 | DeBoer et al. | Jul 2014 | B2 |
8778017 | Eliasen et al. | Jul 2014 | B2 |
8834564 | Tuval et al. | Sep 2014 | B2 |
8840663 | Salahieh et al. | Sep 2014 | B2 |
8876894 | Tuval et al. | Nov 2014 | B2 |
8876895 | Tuval et al. | Nov 2014 | B2 |
8920369 | Salahieh | Dec 2014 | B2 |
8945177 | Dell et al. | Feb 2015 | B2 |
9034032 | McLean et al. | May 2015 | B2 |
9061119 | Le | Jun 2015 | B2 |
9155619 | Liu | Oct 2015 | B2 |
9198757 | Schroeder et al. | Dec 2015 | B2 |
9259317 | Wilson et al. | Feb 2016 | B2 |
9301834 | Tuval et al. | Apr 2016 | B2 |
9308360 | Bishop et al. | Apr 2016 | B2 |
9339384 | Tran | May 2016 | B2 |
9387071 | Tuval et al. | Jul 2016 | B2 |
9427327 | Parrish | Aug 2016 | B2 |
9439763 | Geist et al. | Sep 2016 | B2 |
9510837 | Seguin | Dec 2016 | B2 |
9510946 | Chau et al. | Dec 2016 | B2 |
9572660 | Braido et al. | Feb 2017 | B2 |
9586025 | Salahieh | Mar 2017 | B2 |
9642704 | Tuval et al. | May 2017 | B2 |
9700445 | Martin et al. | Jul 2017 | B2 |
9775963 | Miller | Oct 2017 | B2 |
D809139 | Marsot et al. | Jan 2018 | S |
9889002 | Bonhoeffer et al. | Feb 2018 | B2 |
9913717 | Chau | Mar 2018 | B2 |
9949824 | Bonhoeffer et al. | Apr 2018 | B2 |
10076327 | Ellis et al. | Sep 2018 | B2 |
10076415 | Metchik et al. | Sep 2018 | B1 |
10076638 | Tran | Sep 2018 | B2 |
10105221 | Siegel | Oct 2018 | B2 |
10105222 | Metchik et al. | Oct 2018 | B1 |
10111751 | Metchik et al. | Oct 2018 | B1 |
10123873 | Metchik et al. | Nov 2018 | B1 |
10130475 | Metchik et al. | Nov 2018 | B1 |
10136993 | Metchik et al. | Nov 2018 | B1 |
10159570 | Metchik et al. | Dec 2018 | B1 |
10226309 | Ho et al. | Mar 2019 | B2 |
10231837 | Metchik et al. | Mar 2019 | B1 |
10238494 | McNiven et al. | Mar 2019 | B2 |
10238495 | Marsot et al. | Mar 2019 | B2 |
10299924 | Kizuka | May 2019 | B2 |
10376673 | Van Hoven et al. | Aug 2019 | B2 |
20010005787 | Oz et al. | Jun 2001 | A1 |
20020013571 | Goldfarb et al. | Jan 2002 | A1 |
20020107531 | Schreck et al. | Aug 2002 | A1 |
20020173811 | Tu et al. | Nov 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20030097119 | Garabedian | May 2003 | A1 |
20030187467 | Schreck | Oct 2003 | A1 |
20030208231 | Williamson et al. | Nov 2003 | A1 |
20040003819 | St. Goar et al. | Jan 2004 | A1 |
20040034365 | Lentz et al. | Feb 2004 | A1 |
20040044365 | Bachman | Mar 2004 | A1 |
20040049207 | Goldfarb et al. | Mar 2004 | A1 |
20040122360 | Waldhauser et al. | Jun 2004 | A1 |
20040127981 | Randert et al. | Jul 2004 | A1 |
20040127982 | Machold et al. | Jul 2004 | A1 |
20040147943 | Kobayashi | Jul 2004 | A1 |
20040162543 | Schaefer | Aug 2004 | A1 |
20040181206 | Chiu et al. | Sep 2004 | A1 |
20040181238 | Zarbatany et al. | Sep 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040220593 | Greenhalgh | Nov 2004 | A1 |
20050049618 | Masuda et al. | Mar 2005 | A1 |
20050143767 | Kimura et al. | Jun 2005 | A1 |
20050165429 | Douglas et al. | Jul 2005 | A1 |
20050182388 | Garabedian et al. | Aug 2005 | A1 |
20050251183 | Buckman et al. | Nov 2005 | A1 |
20050288786 | Chanduszko | Dec 2005 | A1 |
20060100649 | Hart | May 2006 | A1 |
20060122647 | Callaghan et al. | Jun 2006 | A1 |
20060178700 | Quinn | Aug 2006 | A1 |
20060224169 | Weisenburgh | Oct 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070021779 | Garvin et al. | Jan 2007 | A1 |
20070032807 | Ortiz et al. | Feb 2007 | A1 |
20070093857 | Rogers et al. | Apr 2007 | A1 |
20070191154 | Genereux et al. | Aug 2007 | A1 |
20070197858 | Goldfarb et al. | Aug 2007 | A1 |
20070198038 | Cohen et al. | Aug 2007 | A1 |
20070282414 | Soltis et al. | Dec 2007 | A1 |
20080039743 | Fox et al. | Feb 2008 | A1 |
20080039953 | Davis et al. | Feb 2008 | A1 |
20080065011 | Marchand et al. | Mar 2008 | A1 |
20080065149 | Thielen et al. | Mar 2008 | A1 |
20080077144 | Crofford | Mar 2008 | A1 |
20080140089 | Kogiso et al. | Jun 2008 | A1 |
20080147093 | Roskopf et al. | Jun 2008 | A1 |
20080147112 | Sheets et al. | Jun 2008 | A1 |
20080167713 | Bolling | Jul 2008 | A1 |
20080177300 | Mas et al. | Jul 2008 | A1 |
20080255427 | Satake et al. | Oct 2008 | A1 |
20080294247 | Yang et al. | Nov 2008 | A1 |
20080319455 | Harris et al. | Dec 2008 | A1 |
20090131865 | Partlett et al. | May 2009 | A1 |
20090156995 | Martin et al. | Jun 2009 | A1 |
20090163934 | Raschdorf, Jr. et al. | Jun 2009 | A1 |
20090275902 | Heeps et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287304 | Dahlgren et al. | Nov 2009 | A1 |
20100022823 | Goldfarb et al. | Jan 2010 | A1 |
20100036484 | Hariton et al. | Feb 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100057037 | Webler | Mar 2010 | A1 |
20100094317 | Goldfarb et al. | Apr 2010 | A1 |
20100324595 | Linder et al. | Dec 2010 | A1 |
20100331776 | Salahieh | Dec 2010 | A1 |
20110082538 | Dahlgren et al. | Apr 2011 | A1 |
20110137410 | Hacohen | Jun 2011 | A1 |
20110245855 | Matsuoka et al. | Oct 2011 | A1 |
20110282379 | Lee et al. | Nov 2011 | A1 |
20110295281 | Mizumoto et al. | Dec 2011 | A1 |
20120109160 | Martinez et al. | May 2012 | A1 |
20120116419 | Sigmon, Jr. | May 2012 | A1 |
20120123327 | Miller | May 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120209318 | Qadeer | Aug 2012 | A1 |
20120239142 | Liu et al. | Sep 2012 | A1 |
20120277730 | Salahieh | Nov 2012 | A1 |
20130030519 | Tran et al. | Jan 2013 | A1 |
20130046298 | Kaufman et al. | Feb 2013 | A1 |
20130066341 | Ketai et al. | Mar 2013 | A1 |
20130066342 | Dell et al. | Mar 2013 | A1 |
20130072945 | Terada | Mar 2013 | A1 |
20130073034 | Wilson et al. | Mar 2013 | A1 |
20130116705 | Salahieh | May 2013 | A1 |
20130190861 | Chau et al. | Jul 2013 | A1 |
20130268069 | Zakai et al. | Oct 2013 | A1 |
20140046433 | Kovalsky | Feb 2014 | A1 |
20140058324 | Salahieh | Feb 2014 | A1 |
20140058411 | Soutorine et al. | Feb 2014 | A1 |
20140067048 | Chau et al. | Mar 2014 | A1 |
20140067052 | Chau et al. | Mar 2014 | A1 |
20140107623 | Salahieh | Apr 2014 | A1 |
20140135685 | Kabe et al. | May 2014 | A1 |
20140236198 | Goldfarb et al. | Aug 2014 | A1 |
20140243968 | Padala | Aug 2014 | A1 |
20140316428 | Golan | Oct 2014 | A1 |
20150039084 | Levi et al. | Feb 2015 | A1 |
20150057704 | Takahashi | Feb 2015 | A1 |
20150073341 | Salahieh et al. | Mar 2015 | A1 |
20150094656 | Salahieh | Apr 2015 | A1 |
20150105808 | Gordon et al. | Apr 2015 | A1 |
20150157268 | Winshtein et al. | Jun 2015 | A1 |
20150196390 | Ma et al. | Jul 2015 | A1 |
20150223793 | Goldfarb et al. | Aug 2015 | A1 |
20150230919 | Chau et al. | Aug 2015 | A1 |
20150238313 | Spence et al. | Aug 2015 | A1 |
20150257883 | Basude et al. | Sep 2015 | A1 |
20150313592 | Coillard-Lavirotte et al. | Nov 2015 | A1 |
20160022970 | Forcucci et al. | Jan 2016 | A1 |
20160106539 | Buchbinder et al. | Apr 2016 | A1 |
20160113764 | Sheahan et al. | Apr 2016 | A1 |
20160113766 | Ganesan et al. | Apr 2016 | A1 |
20160155987 | Yoo et al. | Jun 2016 | A1 |
20160158497 | Tran et al. | Jun 2016 | A1 |
20160174979 | Wei | Jun 2016 | A1 |
20160174981 | Fago et al. | Jun 2016 | A1 |
20160242906 | Morriss et al. | Aug 2016 | A1 |
20160287387 | Wei | Oct 2016 | A1 |
20160317290 | Chau et al. | Nov 2016 | A1 |
20160331523 | Chau et al. | Nov 2016 | A1 |
20160354082 | Oz et al. | Dec 2016 | A1 |
20170020521 | Krone et al. | Jan 2017 | A1 |
20170035561 | Rowe et al. | Feb 2017 | A1 |
20170035566 | Krone et al. | Feb 2017 | A1 |
20170042456 | Budiman | Feb 2017 | A1 |
20170049455 | Seguin | Feb 2017 | A1 |
20170100236 | Robertson et al. | Apr 2017 | A1 |
20170173303 | Salahieh | Jun 2017 | A1 |
20170239048 | Goldfarb et al. | Aug 2017 | A1 |
20170281330 | Liljegren | Oct 2017 | A1 |
20170348102 | Cousins et al. | Dec 2017 | A1 |
20180008311 | Shiroff et al. | Jan 2018 | A1 |
20180021044 | Miller et al. | Jan 2018 | A1 |
20180021134 | McNiven et al. | Jan 2018 | A1 |
20180078271 | Thrasher, III | Mar 2018 | A1 |
20180126124 | Winston | May 2018 | A1 |
20180146964 | Garcia et al. | May 2018 | A1 |
20180146966 | Hernandez et al. | May 2018 | A1 |
20180153552 | King et al. | Jun 2018 | A1 |
20180161159 | Lee et al. | Jun 2018 | A1 |
20180221147 | Ganesan et al. | Aug 2018 | A1 |
20180235657 | Abunassar | Aug 2018 | A1 |
20180243086 | Barbarino et al. | Aug 2018 | A1 |
20180258665 | Reddy et al. | Sep 2018 | A1 |
20180263767 | Chau et al. | Sep 2018 | A1 |
20180296326 | Dixon et al. | Oct 2018 | A1 |
20180296327 | Dixon et al. | Oct 2018 | A1 |
20180296328 | Dixon et al. | Oct 2018 | A1 |
20180296329 | Dixon et al. | Oct 2018 | A1 |
20180296330 | Dixon et al. | Oct 2018 | A1 |
20180296331 | Dixon et al. | Oct 2018 | A1 |
20180296332 | Dixon et al. | Oct 2018 | A1 |
20180296333 | Dixon et al. | Oct 2018 | A1 |
20180296334 | Dixon et al. | Oct 2018 | A1 |
20180325671 | Abunassar et al. | Nov 2018 | A1 |
20190000613 | Delgado et al. | Jan 2019 | A1 |
20190000623 | Pan et al. | Jan 2019 | A1 |
20190008642 | Delgado et al. | Jan 2019 | A1 |
20190008643 | Delgado et al. | Jan 2019 | A1 |
20190015199 | Delgado et al. | Jan 2019 | A1 |
20190015200 | Delgado et al. | Jan 2019 | A1 |
20190015207 | Delgado et al. | Jan 2019 | A1 |
20190015208 | Delgado et al. | Jan 2019 | A1 |
20190021851 | Delgado et al. | Jan 2019 | A1 |
20190021852 | Delgado et al. | Jan 2019 | A1 |
20190029810 | Delgado et al. | Jan 2019 | A1 |
20190029813 | Delgado et al. | Jan 2019 | A1 |
20190030285 | Prabhu et al. | Jan 2019 | A1 |
20190060058 | Delgado et al. | Feb 2019 | A1 |
20190060059 | Delgado et al. | Feb 2019 | A1 |
20190060072 | Zeng | Feb 2019 | A1 |
20190060073 | Delgado et al. | Feb 2019 | A1 |
20190060074 | Delgado et al. | Feb 2019 | A1 |
20190060075 | Delgado et al. | Feb 2019 | A1 |
20190069991 | Metchik et al. | Mar 2019 | A1 |
20190069992 | Delgado et al. | Mar 2019 | A1 |
20190069993 | Delgado et al. | Mar 2019 | A1 |
20190167197 | Abunassar et al. | Jun 2019 | A1 |
20190261995 | Goldfarb et al. | Aug 2019 | A1 |
20190261996 | Goldfarb et al. | Aug 2019 | A1 |
20190261997 | Goldfarb et al. | Aug 2019 | A1 |
Number | Date | Country |
---|---|---|
1142351 | Feb 1997 | CN |
0098100 | Jan 1984 | EP |
2146050 | Feb 1973 | FR |
9711600 | Mar 1997 | FR |
2017015632 | Jan 2017 | WO |
2018195015 | Oct 2018 | WO |
2018195201 | Oct 2018 | WO |
2018195215 | Oct 2018 | WO |
2019139904 | Jul 2019 | WO |
Entry |
---|
Al Zaibag et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenosis”, British Heart Journal. vol. 57, No. 1. Jan. 1987. |
Al-Khaja et al., “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications”, European Journal of Cardio-thoracic Surgery 3: pp. 305-311, 1989. |
Andersen, H.R. “History of Percutaneous Aortic Valve Prosthesis,” Herz No. 34. pp. 343-346. 2009. |
Benchimol et al., “Simultaneous Left Ventricular Echocardiography and Aortic Blood Velocity During Rapid Right Ventricular Pacing in Man”, The American Journal of the Medical Sciences, vol. 273, No. 1, pp. 55-62, 1977. |
Dake et al., “Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms”, The New England Journal of Medicine, vol. 331, No. 26, pp. 1729-1734, Dec. 29, 1994. |
Dotter et al., “Transluminal Treatment of Arteriosclerotic Obstruction: Description of a New Technic and a Preliminary Report of Its Application”, Circulation; vol. XXX, pp. 654-670, 1964. |
Inoune, M.D., Kanji, et al.; “Clinical Application of Transvenous Mitral Commissurotomy by a New Balloon Catheter,” The Journal of Thoracic and Cardiovascular Surgery 87:394-402, 1984. |
Kolata, Gina “Device that Opens Clogged Arteries Gets a Failing Grade in a New Study”, The New York Times, http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-arteries-gets-a-faili . . . , pp. 1-2, wrriten Jan. 3, 199, web page access Jul. 29, 2009. |
Lawrence, Jr., et al., “Percutaneous Endovascular Graft: Experimental Evaluation”, Cardiovascular Radiology 163, pp. 357-360, May 1987. |
Porstmann et al., “Der Verschluß des Ductus Arteriosus Persistens Ohne Thorakotomie”, Thoraxchirurgie Vaskuiäre Chirurgie, Band 15, Heft 2, Stuttgart, im Apr. 1967, pp. 199-203. |
Rashkind et al., “Creation of an Atrial Septal Defect Without Thoracotomy: A Pallative Approach to Complete Transposition of the Great Arteries”, The Journal of the American Medical Association, vol. 196, No. 11, pp. 173-174, Jun. 13, 1956. |
Reul RM et al., “Mitral valve reconstruction for mitral insufficiency”, Prog Cardiovasc Dis., vol. 39, Issue—6, May-Jun. 1997. |
Rosch, M.D., Josef, “The Birth, Early Years and Future of Interventional Radiology,” J Vasc Intery Radiol 2003; 14:841-853. |
Sabbah et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview”, Journal of Cardiac Surgery, vol. 4, No. 4, pp. 302-309, Dec. 1989. |
Selby et al., “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems”, Radiology: 176. pp. 535-538, 1990. |
Serruys et al., “Stenting of Coronary Arteries. Are we the Sorcerer's Apprentice?”, European Heart Journal, 10, 774-782, pp. 37-45, 1989. |
Sigwart, Ulrich, “An Overview of Intravascular Stents: Old and New,” Chapter 48, Textbook of Interventional Cardiology, 2nd Edition, W.B. Saunders Company, Philadelphia, PA, © 1994, 1990, pp. 803-815. |
Uchida et al., “Modifications of Gianturco Expandable Wire Stents”, Technical Note, American Roentgen Ray Society, pp. 1185-1187, May 1988. |
Watt et al., “Intravenous Adenosine in the Treatment of Supraventricular Tachycardia: A Dose-Ranging Study and Interaction with Dipyridarnole”, Br. J. Clin. Pharmac. 21, pp. 227-230, 1986. |
Almagor et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits”, Journal of the American College of Cardiology, vol. 16, No. 5, pp. 1310-1314, Nov. 15, 1990. |
Andersen, et al., “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” European Heart Journal (1992), 13, 704-708. |
Batista RJ et al., “Partial left ventriculectomy to treat end-stage heart disease”, Ann Thorac Surg., vol. 64, Issue—3, pp. 634-638, Sep. 1997. |
Beall AC Jr. et al.,“Clinical experience with a dacron velour-covered teflon-disc mitral-valve prosthesis”, Ann Thorac Surg., vol.—5, Issue 5, pp. 402-410, May 1968. |
Fucci et al., “Improved results with mitral valve repair using new surgical techniques”, Eur J Cardiothorac Surg. 1995;Issue 9, vol.—11, pp. 621-626 |
Maisano F et al., ‘The edge-to-edge technique: a simplified method to correct mitral insufficiency’, Eur J Cardiothorac Surg., vol. 13, Issue—3, pp. 240-245, Mar. 1998. |
Pavcnik, M.D., Ph.D., Dusan, et al. “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology 1992; 183:151-154. |
Ross, D.N, “Aortic Valve Surgery”, Surgery of the Aortic Valves, Guy's Hospital, London, pp. 192-197. |
Uma{hacek over (n)}a JP et al., Bow-tie' mitral valve repair: an adjuvant technique for ischemic mitral regurgitation, Ann Thorac Surg., vol. 66, Issue—6, pp. 1640-1646, Nov. 1998. |
Urban, Philip MD, “Coronary Artery Stenting”, Editions Medecine et Hygiene, Geneve, pp. 1-47; 1991. |
Wheatley, David J., “Valve Prosthesis”, Rob & Smith's Operative Surgery, pp. 415-424, 1986. |
Praz Et A., “Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study,” Lancet vol. 390, pp. 773-780, 2017. |
Number | Date | Country | |
---|---|---|---|
20180126124 A1 | May 2018 | US |
Number | Date | Country | |
---|---|---|---|
62418528 | Nov 2016 | US |